PT1471065E - Novos compostos de 1,2,4-triazole - Google Patents

Novos compostos de 1,2,4-triazole Download PDF

Info

Publication number
PT1471065E
PT1471065E PT02781876T PT02781876T PT1471065E PT 1471065 E PT1471065 E PT 1471065E PT 02781876 T PT02781876 T PT 02781876T PT 02781876 T PT02781876 T PT 02781876T PT 1471065 E PT1471065 E PT 1471065E
Authority
PT
Portugal
Prior art keywords
novel
triazole compound
triazole
compound
Prior art date
Application number
PT02781876T
Other languages
English (en)
Inventor
Hiroshi Nakamura
Soichi Kaneda
Takahiro Sato
Naoki Ashizawa
Koji Matsumoto
Takashi Iwanaga
Tsutomu Inoue
Original Assignee
Fuji Yakuhin Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Yakuhin Co Ltd filed Critical Fuji Yakuhin Co Ltd
Publication of PT1471065E publication Critical patent/PT1471065E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT02781876T 2002-01-28 2002-12-03 Novos compostos de 1,2,4-triazole PT1471065E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002017825 2002-01-28

Publications (1)

Publication Number Publication Date
PT1471065E true PT1471065E (pt) 2008-03-13

Family

ID=27653386

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02781876T PT1471065E (pt) 2002-01-28 2002-12-03 Novos compostos de 1,2,4-triazole

Country Status (22)

Country Link
US (1) US7074816B2 (pt)
EP (1) EP1471065B1 (pt)
JP (1) JP3600832B2 (pt)
CN (1) CN1561340B (pt)
AR (1) AR042602A1 (pt)
AT (1) ATE387438T1 (pt)
AU (1) AU2002349754B2 (pt)
BR (1) BRPI0212775B8 (pt)
CA (1) CA2462132C (pt)
DE (1) DE60225341T2 (pt)
DK (1) DK1471065T3 (pt)
ES (1) ES2300486T3 (pt)
HK (1) HK1067132A1 (pt)
MX (1) MXPA04004037A (pt)
NO (1) NO326941B1 (pt)
NZ (1) NZ531673A (pt)
PL (1) PL208260B1 (pt)
PT (1) PT1471065E (pt)
RU (1) RU2293733C2 (pt)
TW (1) TWI257926B (pt)
WO (1) WO2003064410A1 (pt)
ZA (1) ZA200401777B (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005009991A1 (ja) * 2003-07-24 2005-02-03 Fujiyakuhin Co., Ltd. １，２，４−トリアゾール化合物の製造方法及びその中間体
US20060189811A1 (en) * 2004-07-23 2006-08-24 Fujiyakuhin Co., Ltd. Process for producing 1,2,4-triazole compound and intermediate therefor
JP2008545627A (ja) 2005-05-09 2008-12-18 タツプ・フアーマシユーテイカル・プロダクツ・インコーポレイテツド 腎結石症を治療する方法
CA2617248C (en) * 2005-08-03 2015-09-29 Tap Pharmaceutical Products, Inc. Methods for treating hypertension
CN101282936B (zh) 2005-10-07 2012-05-16 橘生药品工业株式会社 氮化杂环化合物及包含其的药物组合物
EP3219319A1 (en) * 2006-06-22 2017-09-20 Nippon Chemiphar Co., Ltd. Agent for overcoming resistance to anti-cancer agent
EP2050467B1 (en) * 2006-07-19 2014-09-10 Nippon Medical School Foundation Therapeutic agent for amyotrophic lateral sclerosis
CN101677999A (zh) * 2006-11-13 2010-03-24 塔普医药产品公司 使用黄嘌呤氧化还原酶抑制剂保护肾功能的方法
US20090124623A1 (en) * 2006-11-13 2009-05-14 Christopher Lademacher Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
US20090042887A1 (en) * 2007-01-19 2009-02-12 Tap Pharmaceutical Products, Inc. Methods for Preventing or Reducing the Number of Gout Flares Using Xanthine Oxidoreductase Inhibitors and Anti-Inflammatory Agents
JO2784B1 (en) * 2007-10-18 2014-03-15 شركة جانسين فارماسوتيكا ان. في 5,3,1 - Triazole substitute derivative
ME01294B (me) 2007-11-27 2013-06-20 Ardea Biosciences Inc Nova jedinjenja i kompozicije i metode upotrebe
EP2165705A1 (en) 2008-09-18 2010-03-24 Centre National de la Recherche Scientifique (CNRS) Use of a compound capable of reducing the uric acid level for the prevention and/or the treatment of lung inflammation and fibrosis
US20100311756A1 (en) * 2009-01-22 2010-12-09 Takeda Pharmaceuticals North America, Inc. Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
WO2012033941A1 (en) 2010-09-10 2012-03-15 Takeda Pharmaceuticals North America, Inc. Methods for concomitant treatment of theophylline and febuxostat
WO2012060308A1 (ja) * 2010-11-01 2012-05-10 株式会社 三和化学研究所 腎機能障害の予防又は治療に用いる医薬
KR101530141B1 (ko) 2010-12-17 2015-06-18 미쓰비시 타나베 파마 코퍼레이션 연속 아리시클릭 화합물
US8541094B2 (en) 2011-03-01 2013-09-24 Empire Technology Development Llc Temperature controlled variable reflectivity coatings
RU2476428C1 (ru) * 2011-09-01 2013-02-27 Государственное образовательное учреждение высшего профессионального образования "Южно-Российский государственный технический университет (Новочеркасский политехнический институт)" Способ получения дигидрохлорида 5-амино-3-аминометил-1,2,4-триазола
ES2690315T3 (es) 2012-06-15 2018-11-20 Mitsubishi Tanabe Pharma Corporation Compuestos de imidazol y triazol como inhibidores de DGAT-1
RU2639149C2 (ru) * 2012-07-25 2017-12-20 Фудзиякухин Ко., Лтд Кристаллический полиморф 4-[5-(пиридин-4-ил)-1н-1,2,4-триазол-3-ил]-пиридин-2-карбонитрила и способ его получения
RU2644766C2 (ru) * 2012-07-25 2018-02-14 Фудзиякухин Ко., Лтд. Способ получения 4-[5-(пиридин-4-ил)-1н-1,2,4-триазол-3-ил]пиридин-2-карбонитрила и его промежуточное соединение
CN103724329B (zh) * 2013-12-23 2015-02-18 济南百诺医药科技开发有限公司 4-[5-(吡啶-4-基)-1h-[1,2,4]三唑-3-基]吡啶-2-甲腈的制备方法
CN104042577B (zh) * 2014-06-13 2016-08-24 安徽省逸欣铭医药科技有限公司 一种稳定的托匹司他片及其制备方法
CN105315260A (zh) * 2014-07-29 2016-02-10 北京海步医药科技股份有限公司 一种托布司他一水合物晶型及其制备方法
CN105348264B (zh) * 2014-08-18 2018-01-16 上海医药工业研究院 一种托吡司他的合成方法
CN105367490B (zh) * 2014-08-18 2019-01-04 上海医药工业研究院 合成托吡司他的新中间体及其制备方法
CN104151297B (zh) * 2014-08-27 2016-03-16 王庆本 4-[5-(吡啶-4-基)-1h-[1，2，4]三唑-3-基]吡啶-2-甲腈的制备方法
JP6684264B2 (ja) * 2015-02-17 2020-04-22 株式会社三和化学研究所 心不全の予防又は治療のための医薬
WO2016136727A1 (ja) 2015-02-24 2016-09-01 国立大学法人鳥取大学 認知症の予防及び／又は治療のための医薬
WO2016134854A1 (en) 2015-02-25 2016-09-01 Pharmathen S.A. Methods for the preparation of topiroxostat and intermediates thereof
CN105693699B (zh) * 2015-03-30 2019-06-18 苏州晶云药物科技股份有限公司 托吡司他的晶型及其制备方法
CN104910068B (zh) * 2015-04-24 2017-07-14 南京医科大学 一种2‑氰基异烟酸酰肼1.5对甲苯磺酸盐的合成方法
CN106279111A (zh) * 2015-05-12 2017-01-04 北京济美堂医药研究有限公司 一种精制托吡司他的新方法
CN104961730B (zh) * 2015-06-18 2017-05-17 山东金城医药化工股份有限公司 托吡司他新晶型及其制备方法
CN105130958B (zh) * 2015-08-31 2017-10-31 济南康和医药科技有限公司 5‑(2‑氰基4‑吡啶基)‑3‑(4‑吡啶基)‑1,2,4‑三唑的制备工艺
CN105294656A (zh) * 2015-10-10 2016-02-03 大道隆达（北京）医药科技发展有限公司 一种托匹司他的制备工艺和方法
CN106336399A (zh) * 2015-11-03 2017-01-18 江苏悦兴药业有限公司 托匹司他工艺杂质的制备方法
CN105294584A (zh) * 2015-11-30 2016-02-03 中国医科大学 1-取代苯基-1h-1,2,3-三唑类化合物、制备方法及其用途
CN105399732A (zh) * 2015-12-07 2016-03-16 青岛正大海尔制药有限公司 一种托匹司他的制备方法
CN106008465A (zh) * 2016-03-16 2016-10-12 江苏悦兴药业有限公司 一种托匹司他杂质的合成方法
CN108250183A (zh) * 2016-12-29 2018-07-06 北京诚济制药有限公司 一种高纯度的托匹司他的制备方法
CN109721586B (zh) * 2017-10-27 2021-03-02 中国医科大学 一种5-苄基-3-吡啶基-1h-1,2,4-三唑类化合物及其制备方法和用途
CN107652271B (zh) * 2017-11-06 2020-06-16 上海中拓医药科技有限公司 一种托匹司他晶型i的制备方法
CN108017619B (zh) * 2017-12-06 2020-08-11 成都惟邦药业有限公司 一种托匹司他杂质及其制备方法
CN113354616B (zh) * 2020-03-05 2024-03-26 中国医学科学院药物研究所 二芳基-1,2,4-三唑类化合物及其制法和药物用途
CN113666909B (zh) * 2020-05-14 2024-07-02 鲁南制药集团股份有限公司 一种托匹司他的制备方法
CN114773262B (zh) * 2022-05-19 2024-05-07 兄弟科技股份有限公司 2-氰基-4-吡啶羧酸甲酯的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7112373A (pt) * 1970-09-25 1972-03-28
US3947577A (en) * 1973-05-21 1976-03-30 Merck & Co., Inc. Anti-hyperuricemia composition
US3928361A (en) * 1973-05-21 1975-12-23 Merck & Co Inc 1-(Sulfamoylphenylalkyl)-3,5-dipyridyl-1,2,4 triazoles
US3882134A (en) * 1973-05-21 1975-05-06 Merck & Co Inc 1-Substituted-3,5-dipyridyl-1,2,4-triazoles
US3963731A (en) * 1973-05-21 1976-06-15 Merck & Co., Inc. Pyridyl containing 1-benzenesulfonyl triazoles
US3984558A (en) * 1973-05-21 1976-10-05 Merck & Co., Inc. 1,3,5-Trisubstituted-1,2,4-triazole compounds used as bronchodilators
US4104393A (en) * 1976-04-02 1978-08-01 Merck & Co., Inc. 1,3,5-Trisubstituted-1,2,4-triazole compounds
WO1993011433A1 (en) * 1991-12-05 1993-06-10 Wallac Oy Luminescent lanthanide chelates
AU1130700A (en) * 1998-10-23 2000-05-15 Dow Agrosciences Llc Insecticidal 1-(substituted pyridyl)-1,2,4-triazoles
ATE375340T1 (de) * 2001-02-21 2007-10-15 Nps Pharma Inc Heteropolycyclische verbindungen und deren verwendung als metabotrope glutamatrezeptorantagonisten

Also Published As

Publication number Publication date
NO20041075L (no) 2004-03-15
NO326941B1 (no) 2009-03-16
DE60225341D1 (de) 2008-04-10
RU2004106554A (ru) 2005-07-27
NZ531673A (en) 2006-06-30
ATE387438T1 (de) 2008-03-15
JPWO2003064410A1 (ja) 2005-05-26
EP1471065B1 (en) 2008-02-27
TWI257926B (en) 2006-07-11
WO2003064410A1 (fr) 2003-08-07
PL368672A1 (en) 2005-04-04
CN1561340B (zh) 2012-05-23
EP1471065A1 (en) 2004-10-27
DK1471065T3 (da) 2008-03-25
US20050004175A1 (en) 2005-01-06
MXPA04004037A (es) 2004-07-23
JP3600832B2 (ja) 2004-12-15
CN1561340A (zh) 2005-01-05
ES2300486T3 (es) 2008-06-16
AR042602A1 (es) 2005-06-29
PL208260B1 (pl) 2011-04-29
RU2293733C2 (ru) 2007-02-20
AU2002349754B2 (en) 2008-01-31
CA2462132A1 (en) 2003-08-07
EP1471065A4 (en) 2005-06-15
US7074816B2 (en) 2006-07-11
DE60225341T2 (de) 2009-04-09
HK1067132A1 (pt) 2005-04-01
BRPI0212775B1 (pt) 2017-06-06
BRPI0212775B8 (pt) 2021-05-25
ZA200401777B (en) 2005-08-31
CA2462132C (en) 2010-08-10
TW200302222A (en) 2003-08-01
BR0212775A (pt) 2004-10-13

Similar Documents

Publication Publication Date Title
PL368672A1 (en) Novel 1,2,4-triazole compound
AU2002349754A1 (en) Novel 1,2,4-triazole compound
SI1555267T1 (sl) 2,3-DIHIDRO-6-NITROIMIDAZO(2,1-b)OKSAZOLI
GB0229015D0 (en) New Compound
PL377187A1 (pl) Związki ze skondensowanym pierścieniem 1,3-dihydroimidazolowym
MXPA03009558A (es) Compuestos novedosos.
GB0119467D0 (en) Novel compound
GB0221828D0 (en) Novel compound
GB0221679D0 (en) Novel compounds
GB0221829D0 (en) Novel compound
PL397821A1 (pl) Związek1-acetylo-6-fluoro-2-indolinon
GB0204241D0 (en) Compound
GB0224830D0 (en) Compound
GB0213027D0 (en) Compound
GB0200025D0 (en) Novel compounds
GB0207637D0 (en) Novel compound
SI1497256T1 (sl) Substituirane 1,5-diaminopentan-3-olne spojine
GB0211017D0 (en) Novel compounds
GB0208746D0 (en) Novel compounds
ZA200407363B (en) Novel compounds.
GB0223287D0 (en) Novel compound
GB0219819D0 (en) Novel compound
GB0229075D0 (en) Compound
GB0217506D0 (en) Compound
GB0229576D0 (en) Compound